Indication

Myxoid

1 clinical trial

1 drug

Clinical trial

Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

Status: Recruiting, Estimated PCD: 2028-06-01

Drug